Atrium Therapeutics, Inc. (RNA)Healthcare | Biotechnology | San Diego, United States | NasdaqGS
14.41 USD
+0.38
(2.708%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 14.41 Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 9, 2026, 12:25 a.m. EDT
RNA is a highly volatile and speculative stock with a negative earnings outlook, low liquidity, and a lack of dividend history. The stock has been trading near its 52-week low, indicating weak investor sentiment. The company is in the biotechnology sector, which is inherently risky, and its financial metrics, such as negative profit margins and a low current ratio, suggest significant financial distress. Given the lack of reliable earnings and the high risk associated with the industry, it is not advisable to invest in RNA for either short or long-term. The stock is not suitable for dividend investors either, as there is no history of dividend payouts. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 1.2 |
| Market Cap | 223,570,672 |
| Forward P/E | -3.57 |
| Profit Margins | -265.88% |
| Website | https://atriumtherapeutics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.023050845 |
| Address1 | 10,578 Science Center Drive |
| Address2 | Suite 125 |
| All Time High | 16.77 |
| All Time Low | 11.95 |
| Ask | 14.5 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 546,940 |
| Average Daily Volume3 Month | 1,039,842 |
| Average Volume | 1,039,842 |
| Average Volume10Days | 546,940 |
| Bid | 14.34 |
| Bid Size | 1 |
| Book Value | -4.042 |
| City | San Diego |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 14.41 |
| Current Ratio | 0.068 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 14.625 |
| Day Low | 13.99 |
| Display Name | Atrium Therapeutics |
| Earnings Timestamp End | 1,778,533,200 |
| Earnings Timestamp Start | 1,778,533,200 |
| Ebitda | -49,308,000 |
| Ebitda Margins | -2.6484 |
| Eps Forward | -4.03333 |
| Eps Trailing Twelve Months | -4.48 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 13.947143 |
| Fifty Day Average Change | 0.46285725 |
| Fifty Day Average Change Percent | 0.03318653 |
| Fifty Two Week Change Percent | -2.3050845 |
| Fifty Two Week High | 16.77 |
| Fifty Two Week High Change | -2.3600006 |
| Fifty Two Week High Change Percent | -0.14072752 |
| Fifty Two Week Low | 11.95 |
| Fifty Two Week Low Change | 2.46 |
| Fifty Two Week Low Change Percent | 0.20585775 |
| Fifty Two Week Range | 11.95 - 16.77 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,772,202,600,000 |
| Float Shares | 15,036,174 |
| Forward Eps | -4.03333 |
| Forward P E | -3.5727303 |
| Free Cashflow | -11,653,375 |
| Full Exchange Name | NasdaqGS |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -1.37765 |
| Gross Profits | -25,649,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0279 |
| Held Percent Institutions | 0.19198999 |
| Implied Shares Outstanding | 15,514,967 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-02-27 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California. |
| Long Name | Atrium Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 223,570,672 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1972622727 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -49,501,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 223,570,660 |
| Number Of Analyst Opinions | 1 |
| Open | 13.99 |
| Operating Cashflow | -41,129,000 |
| Operating Margins | -33.87893 |
| Payout Ratio | 0.0 |
| Phone | 619 876 0700 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 14.41 |
| Post Market Time | 1,776,456,605 |
| Previous Close | 14.03 |
| Price Hint | 2 |
| Price To Book | -3.5650668 |
| Price To Sales Trailing12 Months | 12.008307 |
| Profit Margins | -2.65877 |
| Quick Ratio | 0.002 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.38 |
| Regular Market Change Percent | 2.70848 |
| Regular Market Day High | 14.625 |
| Regular Market Day Low | 13.99 |
| Regular Market Day Range | 13.99 - 14.625 |
| Regular Market Open | 13.99 |
| Regular Market Previous Close | 14.03 |
| Regular Market Price | 14.41 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 632,784 |
| Return On Assets | -3.99245 |
| Revenue Growth | -0.711 |
| Revenue Per Share | 1.2 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 15,514,966 |
| Shares Percent Shares Out | 0.1233 |
| Shares Short | 1,184,615 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 432,798 |
| Short Name | Atrium Therapeutics, Inc. |
| Short Ratio | 1.88 |
| Source Interval | 15 |
| State | CA |
| Symbol | RNA |
| Target High Price | 25.0 |
| Target Low Price | 25.0 |
| Target Mean Price | 25.0 |
| Target Median Price | 25.0 |
| Total Debt | 3,672,000 |
| Total Revenue | 18,618,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.48 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 13.947143 |
| Two Hundred Day Average Change | 0.46285725 |
| Two Hundred Day Average Change Percent | 0.03318653 |
| Type Disp | Equity |
| Volume | 632,784 |
| Website | https://atriumtherapeutics.com |
| Zip | 92,121 |